SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-05-000126
Filing Date
2005-01-12
Accepted
2005-01-11 18:18:06
Documents
2
Period of Report
2005-01-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. b53093tke8vk.htm 8-K 12823
2 EXHIBIT 99.1 PRESS RELEASE DATED JANUARY 11, 2005 b53093tkexv99w1.htm EX-99.1 12947
  Complete submission text file 0000950135-05-000126.txt   27475
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21481 | Film No.: 05524375
SIC: 2836 Biological Products, (No Diagnostic Substances)